Correlation between glucose transporter-1 expression and 18F-fluoro-2-deoxyglucose uptake on positron emission tomography in lung cancer

General Thoracic and Cardiovascular Surgery

Volumn 58, Issue 8, 2010, Pages 405-410

  Usuda, Katsuo ^a   Sagawa, Motoyasu ^a   Aikawa, Hirokazu ^a   Ueno, Masakatsu ^a   Tanaka, Makoto ^a   MacHida, Yuichiro ^a   Zhao, Xi Tong ^a   Ueda, Yoshimichi ^a   Higashi, Koutaro ^b   Sakuma, Tsutomu ^a  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

^b Asanogawa General Hospital   (Japan)

Author keywords

18F fluoro 2 deoxyglucose positron emission tomography (FDG PET); Glucose transporter 1 (Glut1); Immunostaining; Lung cancer; Tumor size

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE TRANSPORTER 1;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER SIZE; CELL DIFFERENTIATION; CELL TYPE; CLINICAL ARTICLE; CORRELATION COEFFICIENT; DRUG ACCUMULATION; DRUG UPTAKE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG RESECTION; LUNG SQUAMOUS CELL CARCINOMA; MALE; POSITRON EMISSION TOMOGRAPHY; PROTEIN EXPRESSION;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; FEMALE; FLUORODEOXYGLUCOSE F18; GLUCOSE TRANSPORTER TYPE 1; HUMANS; IMMUNOHISTOCHEMISTRY; JAPAN; LUNG NEOPLASMS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS;

EID: 77956040828     PISSN: 18636705     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11748-010-0603-1     Document Type: Article

References (15)

1. K. Kubota T. Matsuzawa T. Fujiwara M. Ito J. Hatazawa K. Ishiwata, et al. 1993 Differential diagnosis of lung tumor with positron emission tomography: a prospective study J Nucl Med 31 1927 1933
2. S.K. Kim M. Allen-Auerbach J. Goldin B.J. Fueger M. Dahlbom M. Brown, et al. 2007 Accuracy of PET/CT in characterization of solitary pulmonary lesions J Nucl Med 48 214 220 17268017
3. 18F]-fluoro-2- deoxy-d-glucose positron emission tomography and computed tomography registration J Comput Assist Tomogr 27 479 484 10.1097/00004728-200307000-00004 12886128
4. M. Younes R.W. Brown M. Stephenson M. Gondo P.T. Cagle 1997 Overexpression of Glut1 and Glut3 in stageI non-small cell lung carcinoma is associated with poor survival Cancer 80 1046 1051 10.1002/(SICI)1097- 0142(19970915)80:6<1046::AID-CNCR6>3.0.CO;2-7 1:STN:280: DyaK2svkvFagtw%3D%3D 9305704
5. R.S. Brown J.Y. Leung P.V. Kison K.R. Zasadny A. Flint R.L. Wahl 1999 Glucose transporters and FDG uptake in untreated primary human non-small cell lung cancer J Nucl Med 40 556 565 1:STN:280:DyaK1M3isV2iuw%3D%3D 10210213
6. 18F] FDG uptake in non-small cell lung cancer Eur J Nucl Med 27 1778 1785 10.1007/s002590000367 1:CAS:528:DC%2BD3cXosVOlsr0%3D 11189940
7. 18F-FDG PET: histologic and immunohistochemical tissue analysis J Nucl Med 42 9 16 1:CAS:528:DC%2BD3MXhtF2nsLc%3D 11197987
8. E.M. Marom T.A. Aloia M.B. Moore M. Hara J.E. Herndon D.H. Harpole, et al. 2001 Correlation of FDG-PET imaging with Glut-1 and Glut-3 expression in early-stage non-small cell lung cancer Lung Cancer 33 99 107 10.1016/S0169-5002(00)00250-6 1:STN:280:DC%2BD3MrgtF2mtQ%3D%3D 11551404
9. 18F-FDG PET results in lung cancer staging J Nucl Med 45 999 1003 1:CAS:528:DC%2BD2cXnsFygtr0%3D 15181136
10. J.W. Keyer Jr. 1995 SUV: standard uptake or silly useless value? J Nucl Med 36 1836 1839
11. K. Kubota 2001 From tumor biology to clinical PET: a review of positron emission tomography (PET) in oncology Ann Nucl Med 15 471 486 10.1007/BF02988499 1:STN:280:DC%2BD387gtVGgsw%3D%3D 11831394
12. K. Higashi Y. Ueda H. Seki K. Yuasa M. Oguchi T. Noguchi, et al. 1998 Fluorine-18-FDG PET imaging is negative in bronchioloalveolar lung carcinoma J Nucl Med 39 1016 1020 1:STN:280:DyaK1c3ovFShtw%3D%3D 9627336
13. M. Tsubamoto K. Kuriyama S. Kido J. Arisawa N. Kohno T. Johkoh, et al. 2002 Detection of lung cancer on chest radiographs: analysis on the basis of size and extent of ground-glass opacity at thin-section CT Radiology 224 139 144 10.1148/radiol.2241001445 12091673
14. H. Uramoto K. Sugio S. Nakata T. So K. Ono M. Sugaya, et al. 2006 Clinical usefulness of FDG-PET in the diagnosis of lung cancer Haigan (Jpn J Lung Cancer) 46 127 131 10.2482/haigan.46.127
15. 18F] FDG uptake and PCNA, Glut-1, and hexokinase-II expressions in cancers and inflammatory lesions of the lung Neoplasia 7 369 379 10.1593/neo.04577